TERT and thyroid cancer: In rare cases, C228T and C250T could occur in different subclones or different cell subpopulations within the same tumor, demonstrating intratumor heterogeneity; (III) young thyroid cancer patients (<45 years old) rarely had the mutation, especially in pediatric cases; (IV) there were ethnic and geographic differences in TERT promoter mutations.